Drug-Related Side Effects and Adverse Reactions: all 449 studies

Page 4 of 5. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• PAINTER: Polymorphism And INcidence of Toxicity in ERibulin TreatmentCompletedNCT02864030Phase 4
• Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized ChildrenCompletedNCT02852590
• Adverse Drug Reactions With Fatal OutcomeCompletedNCT02838212
• " En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic AntimalarialsCompletedNCT02805686Not applicable
• Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare UtilizationCompletedNCT02805270Not applicable
• CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory DrugsCompletedNCT02779530Phase 4
• Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With AmetopCompletedNCT02750137
• Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic AntimalarialsCompletedNCT02719002Not applicable
• Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of AgeCompletedNCT02609919
• Response to Medication RegistryCompletedNCT02593916
• Antipsychotics and Risk of Hyperglycemic EmergenciesCompletedNCT02582736
• Severe Cutaneous Adverse Reactions in ThailandStatus unknownNCT02574988
• Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry StudySuspendedNCT02559960
• HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal MetastasisStatus unknownNCT02549911Phase 2
• Post-market Safety Reassessment of Ulinastatin for InjectionStatus unknownNCT02520570
• Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-PatientsStatus unknownNCT02501486Not applicable
• Acupuncture Prevents Chemobrain in Breast Cancer PatientsCompletedNCT02457039Not applicable
• Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrenceCompletedNCT02447679Phase 2
• Genetics of QT Prolongation With AntiarrhythmicsStatus unknownNCT02439658
• Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTMCompletedNCT02428660Not applicable
• Medication Reconciliation in Comparison to an Extensive Medication Safety CheckCompletedNCT02413957Not applicable
• Clinical Registry of Patients Under Treatment With Atypical AntipsychoticsCompletedNCT02409823
• Pharmacogenomics Registry to Assess Clinical UtilityStatus unknownNCT02374840
• Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and HepatotoxicityStatus unknownNCT02353455
• Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC PatientsStatus unknownNCT02324803Phase 2
• A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic ProgramCompletedNCT02297126Not applicable
• Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo BrasilienseCompletedNCT02278432
• Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry StudyCompletedNCT02239237
• YouScript IMPACT RegistryCompletedNCT02191358
• Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug SelectionCompletedNCT02188134
• How Safe Are Our Pediatric Emergency Departments?CompletedNCT02162147
• The Drug Induced Renal Injury ConsortiumCompletedNCT02159209
• Post-License Safety Evaluation of Influenza Virus VaccineCompletedNCT02136017
• The Effect of Medication Review in High-risk Emergency Department PatientsCompletedNCT02122965Not applicable
• Acute Care for Elders (ACE) Program at OHSU HospitalStatus unknownNCT02119078Not applicable
• Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsonsCompletedNCT02097654Not applicable
• Pharmacogenomic Testing Of the Elderly To Reduce MorbidityStatus unknownNCT02095769
• Post-Marketing Surveillance of the Tanreqing Injection: a Real World StudyCompletedNCT02094638
• Information Systems-enabled Outreach Program for Adverse Drug EventsCompletedNCT02059044Not applicable
• Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-MyalgiaStatus unknownNCT02024568Phase 2
• Personal Health Records and Elder Medication Use QualityCompletedNCT02012712Not applicable
• Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese PatientsStatus unknownNCT02012504
• Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male SubjectsCompletedNCT01979380Phase 1
• Diagnosing Adverse Drug Reactions RegistryStatus unknownNCT01970709
• High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIsStatus unknownNCT01965275Phase 2
• Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target TherapyStatus unknownNCT01963195Phase 2
• Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World StudyCompletedNCT01946919
• the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic OutcomesStatus unknownNCT01906710Not applicable
• The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.CompletedNCT01897870Not applicable
• Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World StudyCompletedNCT01872520
• StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug PoisoningCompletedNCT01861262Not applicable
• Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)Status unknownNCT01830257Phase 4
• Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of DigoxinCompletedNCT01775839Phase 4
• Pain Control After Minimally Invasive Coronary Artery Bypass GraftingTerminatedNCT01770236Phase 4
• Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two YearsCompletedNCT01764204
• Pharmacological Study of High Doses of Ceftriaxone in MeningitidisCompletedNCT01745679Phase 4
• Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care PatientsCompletedNCT01732302Not applicable
• Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir StudyCompletedNCT01679964Phase 4
• The Diagnosis of Beta-lactam Hypersensitivity in ThailandCompletedNCT01667055
• EARNEST Rifabutin Pharmacokinetics (PK) SubstudyStatus unknownNCT01663168Phase 2
• Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPACompletedNCT01614080
• Impact of a Procedure for the Information and Active Participation of the Patient in the Primary Care Prescription of AntihypertensivesCompletedNCT01610817
• Enhancing the Detection and Management of Adverse Drug Events in Nursing HomesCompletedNCT01531088Not applicable
• Adverse Drug Event Prevention Using Structured Pharmacist ReviewCompletedNCT01467128Phase 4
• Prevention of Adverse Drug Events (ADEs) in Hospitalised Older PatientsCompletedNCT01467050Phase 4
• Feasibility of Using a Telemedicine Medication Delivery Unit for Older AdultsWithdrawnNCT01430702Not applicable
• Diagnosis and Physiopathology of Insulin AllergyCompletedNCT01407640Not applicable
• Pre Hospital Evaluation of Video LaryngoscopyWithdrawnNCT01374061Phase 4
• A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant WomenCompletedNCT01354730
• Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic PhenotypeStatus unknownNCT01352559Not applicable
• Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin CreamWithdrawnNCT01349556Not applicable
• Multi-Center Medication Reconciliation Quality Improvement StudyCompletedNCT01337063Not applicable
• An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in BangladeshCompletedNCT01328457Not applicable
• Development of A Technique to Predict Antidepressant Responsiveness in Depressive PatientsStatus unknownNCT01237275Not applicable
• Study to Improve Survival Among HIV-Exposed Infants in BotswanaCompletedNCT01229761Phase 2
• Using Novel Canadian Resources to Improve Medication Reconciliation at DischargeCompletedNCT01179867Not applicable
• Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100CompletedNCT01135680Phase 1
• Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
• Improving Safety by Basic Computerizing Outpatient PrescribingCompletedNCT01091038Phase 2/3
• Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal CancerCompletedNCT01080547Phase 3
• Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology WardCompletedNCT01058122
• Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH)CompletedNCT01038284Not applicable
• Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide ScanningStatus unknownNCT00935246Not applicable
• Celecoxib for Pediatric AdenotonsillectomyCompletedNCT00849966Phase 2
• Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate MedicationStatus unknownNCT00844025Not applicable
• Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed PatientsStatus unknownNCT00817375Not applicable
• Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare BeneficiariesCompletedNCT00773942Not applicable
• Ambulatory Medication Reconciliation Following Hospital DischargeStatus unknownNCT00740675Not applicable
• A Study of Drug-Induced Kidney DiseaseStatus unknownNCT00729014
• Development of a Screening Strategy for Community-based Adverse Drug Related Events in the Emergency DepartmentCompletedNCT00727610
• Enhancing the Safety of Warfarin in Nursing HomesCompletedNCT00682773Not applicable
• Reducing Adverse Drug Events in the Nursing HomeWithdrawnNCT00606606Not applicable
• Electronic Prescribing and Electronic Transmission of Discharge Medication ListsCompletedNCT00603070
• Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal WomenCompletedNCT00491595Phase 1
• Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple MyelomaCompletedNCT00482846Phase 1
• ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug EffectsStatus unknownNCT00437775
• BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWithdrawnNCT00397501Phase 1/2
• Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
• Emergency Pharmacist Safety StudyCompletedNCT00382434
• Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyCompletedNCT00326482

← Drug-Related Side Effects and Adverse Reactions overview